Clinical trial on KeraKlear Non-Penetrating Keratoprosthesis in Spain

A prospective, multicenter clinical trial designed to evaluate the safety and probable benefit of the keraklear non-penetrating keratoprosthesis in subjects with corneal opacity due to severe limbal stem cell deficiency associated with aniridia Summary: Sponsor and address KeraMed, Inc. 4122 East Chapman Avenue 2nd Floor, Suite 26 Orange, CA 92869Tel: 973-276-1414 Fax: 973-276-1882   Study …